Main scenario: consider short positions from corrections below the level of 1.3639 with a target of 1.3090 – 1.2778. Alternative scenario: breakout and consolidation above the level of 1.3639 will al
<p>SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeuti
Leave a Comment